The findings applied to patients with and without insurance, according to the study published online Aug. 24 in the Journal of Clinical Oncology.
“While it is reassuring that most patients in this study received adjuvant chemotherapy on time, the fact that patients traveling more than 50 miles were less likely to receive chemotherapy, regardless of insurance status, is concerning,” said lead author Chun Chieh Lin, senior epidemiologist at the American Cancer Society, in a journal news release.
“It tells us expanded insurance coverage, while important, might not fully address the barriers to patients receiving guideline-recommended treatment,” Lin added.
Copyright HealthDay News 2015. All rights reserved.